The Patent Finder

Maintenance fees coming due

Cancer Research Technology Limited

32 maintenance fees come due in the 12 months from Nov 22, 2026, the next on Dec 9, 2026. Unpaid by Jun 9, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusFee dueLapses if unpaidExpiresConfidence
US 9,050,321Rationally-Designed Anit-avBeta6 Integrin Antibody MFEVP1 and Variants Thereof, Method of Making Such Antibody and the Use Thereof in Treating and Diagnosis of_Disease
In force
Fee due Dec 9, 2026
Lapses if unpaid Jun 9, 2027
 · High confidence
Cancer Research Technology LimitedIn forceDec 9, 2026Jun 9, 2027High confidence
US 10,323,0281,3,4-Thiadiazole Compounds and Their Use in Treating Cancer
In force
Fee due Dec 18, 2026
Lapses if unpaid Jun 21, 2027
 · High confidence
Cancer Research Technology LimitedIn forceDec 18, 2026Jun 21, 2027High confidence
US 11,680,068Compounds Useful as RET Inhibitors
In force
Fee due Dec 20, 2026
Lapses if unpaid Jun 21, 2027
 · High confidence
Cancer Research Technology LimitedIn forceDec 20, 2026Jun 21, 2027High confidence
US 11,697,688ANTI-CD25 for Tumour Specific Cell Depletion
In force
Fee due Jan 11, 2027
Lapses if unpaid Jul 12, 2027
 · High confidence
Cancer Research Technology Limited and Tusk Therapeutics Ltd.In forceJan 11, 2027Jul 12, 2027High confidence
US 10,399,974N2-PHENYL-PYRIDO[3,4- D]PYRIMIDINE-2, 8-Diamine Derivatives and Their Use as MPS1 Inhibitors
In force
Fee due Mar 3, 2027
Lapses if unpaid Sep 3, 2027
 · High confidence
Cancer Research Technology LimitedIn forceMar 3, 2027Sep 3, 2027High confidence
US 10,400,008Modulators of the Src-Kinase Activity for Preventing or Treating Metastatic Cancer
In force
Fee due Mar 3, 2027
Lapses if unpaid Sep 3, 2027
 · High confidence
Cancer Research Technology LimitedIn forceMar 3, 2027Sep 3, 2027High confidence
US 11,753,4051,3,4-Thiadiazole Compounds and Their Use in Treating Cancer
In force
Fee due Mar 12, 2027
Lapses if unpaid Sep 13, 2027
 · High confidence
AstraZeneca AB and Cancer Research Technology LimitedIn forceMar 12, 2027Sep 13, 2027High confidence
US 10,414,726Therapeutic Agents
In force
Fee due Mar 17, 2027
Lapses if unpaid Sep 17, 2027
 · High confidence
Cancer Research Technology LimitedIn forceMar 17, 2027Sep 17, 2027High confidence
US 11,766,434Pyrimidinone Derivatives as CDC7 Inhibitors
In force
Fee due Mar 26, 2027
Lapses if unpaid Sep 27, 2027
 · High confidence
Cancer Research Technology LimitedIn forceMar 26, 2027Sep 27, 2027High confidence
US 10,428,061Autotaxin Inhibitors
In force
Fee due Apr 1, 2027
Lapses if unpaid Oct 1, 2027
 · High confidence
Cancer Research Technology LimitedIn forceApr 1, 2027Oct 1, 2027High confidence
22 more maintenance fees coming due in the 12 months from Nov 22, 2026 · Pro
10 of 32 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Upgrade to Pro
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited